MedPath Search

Found 540544 clinical trials

Sort by:

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Phase 2

Recruiting

Conditions: Atopic Dermatitis

Interventions: Drug: APG777

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Apogee Therapeutics, Inc.

Target Recruit Count: 350

Registration Number: NCT07003425

Locations: 🇺🇸
Investigational Site #25, Fountain Valley, California, United States
🇺🇸
Investigational Site #1, Coral Gables, Florida, United States
🇺🇸
Investigational Site #22, Margate, Florida, United States

and more 29 locations

Tai Po Hidden Carers Support and Home-Based Respite Project

Not Applicable

Not yet recruiting

Conditions: Caregiver Wellbeing

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: The University of Hong Kong

Target Recruit Count: 380

Registration Number: NCT07004855

Locations: 🇭🇰
University of Hong Kong, Hong Kong, Hong Kong

Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality

Not Applicable

Recruiting

Conditions: Hip Fractures

Interventions: Drug: Esketamine combined with dexmedetomidine
Drug: Normal saline

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Peking University Shenzhen Hospital

Target Recruit Count: 96

Registration Number: NCT07002723

Locations: 🇨🇳
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China

Ultrasound-Guided Dry Needling vs PRP for Refractory Lateral Epicondylitis

Not Applicable

Completed

Conditions: Lateral Epicondylitis

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Ankara University

Target Recruit Count: 50

Registration Number: NCT07002879

Locations: 🇹🇷
Ankara University, Ankara, Turkey

Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery

Not Applicable

Not yet recruiting

Conditions: Infection Due to Coronary Artery Bypass Graft (Diagnosis)

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Sohag University

Target Recruit Count: 200

Registration Number: NCT07003750

Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis

Not Applicable

Not yet recruiting

Conditions: Ptosis, Eyelid

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Target Recruit Count: 54

Registration Number: NCT07003308

Locations: 🇪🇸
Rey Juan Carlos Hospital, Móstoles, Madrid, Spain

Diaphragmatic Function and Respiratory Drive in OSA and COPD

Recruiting

Conditions: Obstructive Sleep Apnea

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Nanjing Medical University

Target Recruit Count: 83

Registration Number: NCT07003399

Locations: 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

Phase 1

Not yet recruiting

Conditions: Post Partum Hemorrhage

Interventions: Drug: Tranexamic Acid (TXA)
Device: Placebo

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Patel Hospital, Pakistan

Target Recruit Count: 104

Registration Number: NCT07002749

Locations: 🇵🇰
Patel Hospital, Karachi, Sindh, Pakistan

Evaluation of the Impact of Emergency Advanced Practice Nurses One Year After Implementation in the Adult Emergency Department of a French University Hospital - A Monocentric Cross-sectional Observational Study

Not yet recruiting

Conditions: Advanced Practice Nursing
Emergency Departments
Patient Satisfaction

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 1000

Registration Number: NCT07004270

FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration

Phase 3

Not yet recruiting

Conditions: Low-grade Glioma
Pediatric Low-grade Gliomas
pLGG With BRAF Alteration

Interventions: Drug: Luvometinib
Biological: Chemotherapeutic Agent COG-V/C Carboplatin + Vindesine, Carboplatin, Temozolomide

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Target Recruit Count: 102

Registration Number: NCT07004075

Locations: 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China